109575-05-5

Basic information

• Product Name: Methanone, (4-chloro-3-pyridinyl)phenyl-
• CAS NO: 109575-05-5
• Molecular Formula: C12H8ClNO
• Molecular Weight: 217.655
• Mol File: 109575-05-5.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: Methanone, (4-chloro-3-pyridinyl)phenyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Methanone, (4-chloro-3-pyridinyl)phenyl-(109575-05-5)
• EPA Substance Registry System: Methanone, (4-chloro-3-pyridinyl)phenyl-(109575-05-5)

Safety Data

• Hazardous Substances Data: 109575-05-5(Hazardous Substances Data)

Upstream product

• 7379-35-3 4-chlorpyridine hydrochloride 
• 611-74-5 N,N-dimethylbenzamide 
• 6919-61-5 N-methoxy-N-methylbenzamide 
• 100-52-7 benzaldehyde 
• 626-61-9 4-Chloropyridine 
• 109574-95-0 rac-4-chloro-3-[hydroxy(phenyl)methyl]pyridine 
• 89284-61-7 4-chloro-nicotinonitrile 
• 98-80-6 phenylboronic acid 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 111662-37-4 3-benzoyl-4-(2-phthalimidoethoxy)pyridine 
• 116922-76-0 (4-methoxy-3-pyridyl)phenylmethanone 
• 3810-12-6 (4-aminopyridin-3-yl)(phenyl)methanone 
• 109575-07-7 3-Benzoyl-4-(2-hydroxyethylamino)-pyridine 
• 109575-13-5 3-benzoyl-4(1H)-pyridinone 
• 113277-54-6 3-phenylpyrazolo<4,3-c>pyridine 
• 949003-71-8 (S)-(+)-4-chloro-3-[hydroxy(phenyl)methyl]pyridine 
• 1436852-62-8 phenyl(4-{[(phenylsulfanyl)methyl]sulfanyl}pyridin-3-yl)methanone 
• 1436852-63-9 [4-({[(tert-butyl)sulfanyl]methyl}sulfanyl)pyridin-3-yl](phenyl)methanone 
• 1436852-75-3 3-phenyl-2-(phenylsulfanyl)thieno[3,2-c]pyridine 
• 1436852-76-4 2-[(tert-butyl)sulfanyl]-3-phenylthieno[3,2-c]pyridine 
• 1204772-62-2 C₁₆H₁₀N₄O₂S 
• 1569279-62-4 C₁₈H₁₄N₄O₂S 
• 1462389-28-1 phenyl[4-(3-phenylthieno[3,2-c]pyridin-2-yl)phenyl]methanone 

Relevant articles and documents

COMPOUNDS AND METHODS FOR HEMATOPOIETIC REGENERATION

The invention relates to compounds that promote hematopoietic regeneration. The invention further relates to methods of promoting hematopoietic regeneration using the novel compounds of the invention.

Discovery of 2-(1H-indazol-1-yl)-thiazole derivatives as selective EP 1 receptor antagonists for treatment of overactive bladder by core structure replacement

We have designed a series of potent EP1 receptor antagonists. These antagonists are a series of 2-(1H-indazol-1-yl)-thiazoles in which the core structure was replaced with pyrazole-phenyl groups. In preliminary conscious rat cystometry experiments, two representative candidates, 2 and 22, increased bladder capacity. In particular, the increase using 22 was approximately 2-fold that of the baseline. More detailed profiling of this compound and further optimization of this series promises to provide a novel class of drug for treating overactive bladder (OAB).

BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS

A nitrogen-containing bicyclic heterocyclic compound represented by the following formula (1) is provided. When the compound or a salt thereof is administered to a human being or an animal, the compound has a strong antagonistic action against EP1 recepto